Absci (ABSI) Other Non Operating Income (2020 - 2026)
Absci (ABSI) reported Other Non Operating Income of $1.3 million for Q1 2026, down 12.0% on a YoY basis from $1.5 million in Q1 2025, and down 4.68% sequentially from $1.3 million in Q4 2025.
Absci (ABSI) Other Non Operating Income (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Other Non Operating Income data on file, last reported at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 12.0% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $5.2 million (down 15.04% YoY), and the FY2025 full-year result was $5.4 million, down 15.66% from the prior year.
- Other Non Operating Income declined to $1.3 million in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $2.1 million in Q2 2024 to a low of $125000.0 in Q1 2022.
- A 5-year average of $1.3 million and a median of $1.4 million in 2023 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income surged 1066.4% in 2023 and sank 52.33% in 2025, its largest moves.
- Tracing ABSI's Other Non Operating Income over 5 years: stood at $1.4 million in 2022, then rose by 2.63% to $1.4 million in 2023, then sank by 36.31% to $921000.0 in 2024, then soared by 46.15% to $1.3 million in 2025, then fell by 4.68% to $1.3 million in 2026.
- Business Quant data shows ABSI's Other Non Operating Income at $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Dec 31, 2024 | 921,000.00 |
| Sep 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 2.12 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | 1.57 Mn |
| Jun 30, 2023 | 1.58 Mn |
| Mar 31, 2023 | 1.46 Mn |
| Dec 31, 2022 | 1.41 Mn |
| Sep 30, 2022 | 675,000.00 |
| Jun 30, 2022 | 148,000.00 |
| Mar 31, 2022 | 125,000.00 |
| Dec 31, 2021 | 188,000.00 |
| Sep 30, 2021 | -3.43 Mn |
| Jun 30, 2021 | -28.11 Mn |